Literature DB >> 22773186

The p97/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins.

Rosanna Piccirillo1, Alfred L Goldberg.   

Abstract

The p97/VCP ATPase complex facilitates the extraction and degradation of ubiquitinated proteins from larger structures. We therefore studied if p97 participates to the rapid degradation of myofibrillar proteins during muscle atrophy. Electroporation of a dominant negative p97 (DNp97), but not the WT, into mouse muscle reduced fibre atrophy caused by denervation and food deprivation. DNp97 (acting as a substrate-trap) became associated with specific myofibrillar proteins and its cofactors, Ufd1 and p47, and caused accumulation of ubiquitinated components of thin and thick filaments, which suggests a role for p97 in extracting ubiquitinated proteins from myofibrils. DNp97 expression in myotubes reduced overall proteolysis by proteasomes and lysosomes and blocked the accelerated proteolysis induced by FoxO3, which is essential for atrophy. Expression of p97, Ufd1 and p47 increases following denervation, at times when myofibrils are rapidly degraded. Surprisingly, p97 inhibition, though toxic to most cells, caused rapid growth of myotubes (without enhancing protein synthesis) and hypertrophy of adult muscles. Thus, p97 restrains post-natal muscle growth, and during atrophy, is essential for the accelerated degradation of most muscle proteins.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22773186      PMCID: PMC3411080          DOI: 10.1038/emboj.2012.178

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  77 in total

1.  Role of p97 AAA-ATPase in the retrotranslocation of the cholera toxin A1 chain, a non-ubiquitinated substrate.

Authors:  Michael Kothe; Yihong Ye; Jessica S Wagner; Heidi E De Luca; Eli Kern; Tom A Rapoport; Wayne I Lencer
Journal:  J Biol Chem       Date:  2005-06-02       Impact factor: 5.157

2.  Cdc48 (p97): a "molecular gearbox" in the ubiquitin pathway?

Authors:  Stefan Jentsch; Sebastian Rumpf
Journal:  Trends Biochem Sci       Date:  2006-12-04       Impact factor: 13.807

3.  Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases.

Authors:  Jennifer M Sacheck; Jon-Philippe K Hyatt; Anna Raffaello; R Thomas Jagoe; Roland R Roy; V Reggie Edgerton; Stewart H Lecker; Alfred L Goldberg
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

4.  Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.

Authors:  Conrad C Weihl; Seema Dalal; Alan Pestronk; Phyllis I Hanson
Journal:  Hum Mol Genet       Date:  2005-12-01       Impact factor: 6.150

Review 5.  Diverse functions with a common regulator: ubiquitin takes command of an AAA ATPase.

Authors:  Yihong Ye
Journal:  J Struct Biol       Date:  2006-02-20       Impact factor: 2.867

6.  Valosin-containing protein (p97) is a regulator of endoplasmic reticulum stress and of the degradation of N-end rule and ubiquitin-fusion degradation pathway substrates in mammalian cells.

Authors:  Cezary Wójcik; Maga Rowicka; Andrzej Kudlicki; Dominika Nowis; Elizabeth McConnell; Marek Kujawa; George N DeMartino
Journal:  Mol Biol Cell       Date:  2006-08-16       Impact factor: 4.138

7.  Trim32 is a ubiquitin ligase mutated in limb girdle muscular dystrophy type 2H that binds to skeletal muscle myosin and ubiquitinates actin.

Authors:  Elena Kudryashova; Dmitri Kudryashov; Irina Kramerova; Melissa J Spencer
Journal:  J Mol Biol       Date:  2005-10-10       Impact factor: 5.469

8.  Pathological consequences of VCP mutations on human striated muscle.

Authors:  Christian U Hübbers; Christoph S Clemen; Kristina Kesper; Annett Böddrich; Andreas Hofmann; Outi Kämäräinen; Karen Tolksdorf; Maria Stumpf; Julia Reichelt; Udo Roth; Sabine Krause; Giles Watts; Virginia Kimonis; Mike P Wattjes; Jens Reimann; Dietmar R Thal; Katharina Biermann; Bernd O Evert; Hanns Lochmüller; Erich E Wanker; Benedikt G H Schoser; Angelika A Noegel; Rolf Schröder
Journal:  Brain       Date:  2006-09-19       Impact factor: 13.501

9.  Targeted deletion of p97 (VCP/CDC48) in mouse results in early embryonic lethality.

Authors:  J M M Müller; K Deinhardt; I Rosewell; G Warren; D T Shima
Journal:  Biochem Biophys Res Commun       Date:  2007-01-08       Impact factor: 3.575

10.  Human Fas-associated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in the ubiquitin-proteasome pathway.

Authors:  Eun Joo Song; Seung-Hee Yim; Eunhee Kim; Nam-Soon Kim; Kong-Joo Lee
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

View more
  44 in total

1.  Losing pieces without disintegrating: Contractile protein loss during muscle atrophy.

Authors:  Stefano Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-09       Impact factor: 11.205

2.  Blocking Cancer Growth with Less POMP or Proteasomes.

Authors:  Alfred L Goldberg; Jinghui Zhao; Galen A Collins
Journal:  Mol Cell       Date:  2015-07-16       Impact factor: 17.970

3.  Valosin-containing protein (VCP)-Adaptor Interactions are Exceptionally Dynamic and Subject to Differential Modulation by a VCP Inhibitor.

Authors:  Liang Xue; Emily E Blythe; Elyse C Freiberger; Jennifer L Mamrosh; Alexander S Hebert; Justin M Reitsma; Sonja Hess; Joshua J Coon; Raymond J Deshaies
Journal:  Mol Cell Proteomics       Date:  2016-07-12       Impact factor: 5.911

4.  Myofibril breakdown during atrophy is a delayed response requiring the transcription factor PAX4 and desmin depolymerization.

Authors:  Alexandra Volodin; Idit Kosti; Alfred Lewis Goldberg; Shenhav Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-17       Impact factor: 11.205

5.  VCP maintains lysosomal homeostasis and TFEB activity in differentiated skeletal muscle.

Authors:  Khalid Arhzaouy; Chrisovalantis Papadopoulos; Nina Schulze; Sara K Pittman; Hemmo Meyer; Conrad C Weihl
Journal:  Autophagy       Date:  2019-01-29       Impact factor: 16.016

6.  Histone deacetylase 6 is a FoxO transcription factor-dependent effector in skeletal muscle atrophy.

Authors:  Francesca Ratti; Francis Ramond; Vincent Moncollin; Thomas Simonet; Giulia Milan; Alexandre Méjat; Jean-Luc Thomas; Nathalie Streichenberger; Benoit Gilquin; Patrick Matthias; Saadi Khochbin; Marco Sandri; Laurent Schaeffer
Journal:  J Biol Chem       Date:  2014-12-15       Impact factor: 5.157

7.  Control of proteasomal proteolysis by mTOR.

Authors:  Jinghui Zhao; Gonzalo A Garcia; Alfred L Goldberg
Journal:  Nature       Date:  2016-01-21       Impact factor: 49.962

8.  ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation.

Authors:  Donghoon Lee; Shinichi Takayama; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

Review 9.  Mechanisms of muscle growth and atrophy in mammals and Drosophila.

Authors:  Rosanna Piccirillo; Fabio Demontis; Norbert Perrimon; Alfred L Goldberg
Journal:  Dev Dyn       Date:  2013-10-24       Impact factor: 3.780

10.  Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia.

Authors:  G B Martinelli; D Olivari; A D Re Cecconi; L Talamini; L Ottoboni; S H Lecker; C Stretch; V E Baracos; O F Bathe; A Resovi; R Giavazzi; L Cervo; R Piccirillo
Journal:  Oncogene       Date:  2016-05-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.